Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Researchers use multi-modality imaging to learn more about MINOCA
The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.
FDA approves 2 implantable heart devices from Biotronik
These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago.
Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter
Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.
How to prevent the most common complication after heart surgery
The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.
FDA clears next-gen hybrid system for intravascular imaging
Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Harmony Reynolds, MD, FACC, director of the cardiovascular clinical research center at NYU Langone Health, presented a study at the American College of Cardiology (ACC) 2026 meeting using coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).

Researchers use multi-modality imaging to learn more about MINOCA

The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.

The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026

FDA approves 2 implantable heart devices from Biotronik

These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago.

Nathan McConkey, DO, MPH, an electrophysiologist with Oregon Health & Science University (OHSU), made history when he used the Magic Magnetic Interventional Ablation Catheter.

Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter

Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

How to prevent the most common complication after heart surgery

The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.

FDA clears next-gen hybrid system for intravascular imaging

Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Heart Rhythm 2025 Heart Rhythm Society President Kenneth A. Ellenbogen, MD

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more

Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.

Another win for opportunistic screening: AI turns head CT scans into heart assessments

AI can help care teams get additional value out of routine head CT images.

pediatric patient young patient child chlidren kid

FDA approves fast-acting heart drug for children

Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.